Cargando…
COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177080/ https://www.ncbi.nlm.nih.gov/pubmed/32344292 http://dx.doi.org/10.1016/j.ejca.2020.04.004 |
| _version_ | 1783525141471297536 |
|---|---|
| author | Leonetti, Alessandro Facchinetti, Francesco Zielli, Teresa Brianti, Elena Tiseo, Marcello |
| author_facet | Leonetti, Alessandro Facchinetti, Francesco Zielli, Teresa Brianti, Elena Tiseo, Marcello |
| author_sort | Leonetti, Alessandro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7177080 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71770802020-04-23 COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors Leonetti, Alessandro Facchinetti, Francesco Zielli, Teresa Brianti, Elena Tiseo, Marcello Eur J Cancer Article Elsevier Ltd. 2020-06 2020-04-23 /pmc/articles/PMC7177080/ /pubmed/32344292 http://dx.doi.org/10.1016/j.ejca.2020.04.004 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Leonetti, Alessandro Facchinetti, Francesco Zielli, Teresa Brianti, Elena Tiseo, Marcello COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |
| title | COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |
| title_full | COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |
| title_fullStr | COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |
| title_full_unstemmed | COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |
| title_short | COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |
| title_sort | covid-19 in lung cancer patients receiving alk/ros1 inhibitors |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177080/ https://www.ncbi.nlm.nih.gov/pubmed/32344292 http://dx.doi.org/10.1016/j.ejca.2020.04.004 |
| work_keys_str_mv | AT leonettialessandro covid19inlungcancerpatientsreceivingalkros1inhibitors AT facchinettifrancesco covid19inlungcancerpatientsreceivingalkros1inhibitors AT zielliteresa covid19inlungcancerpatientsreceivingalkros1inhibitors AT briantielena covid19inlungcancerpatientsreceivingalkros1inhibitors AT tiseomarcello covid19inlungcancerpatientsreceivingalkros1inhibitors |